HAMBURG, Germany — n6, the award-winning innovator in next-generation sequencing (NGS) workflow solutions, is proud to announce a major expansion of its European enablement efforts. Building on the momentum of winning the “Best New Product” award at SLAS earlier this year, n6 is deepening its commitment to supporting scientists across Europe by simplifying complex workflows and bringing […]

Empowering Japanese Researchers with End to End Genomic Solutions Partnering with Basepair allows us to deliver a solution that meets modern R&D needs without increasing infrastructure burden.” — Yoshiko Iwai, President & CEO of Iwai Chemicals NEW YORK, NY, UNITED STATES — Basepair Inc. and IWAI Chemicals Co., Ltd. today announced a strategic partnership to bring […]

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling New features include easy-to-use oncology apps, enhanced multiomics pipelines, and AWS F2 support enabling faster turnaround times SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.4 software (v4.4), the industry’s […]

Funding led by new investor Kickstart, with continued support from Silverton Partners and other investors DENVER — Pluto Bio, the leading, AI-powered platform for computational biology, today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies. The round includes participation from […]

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use, fast and flexible NGS data interpretation in a rapidly growing market Franklin complements QCI Interpret, QCI Precision Insights and QIAGEN’s leading genetic databases COSMIC and HGMD VENLO, […]

Closing unlocks the next phase of genomic medicine, enabling an end-to-end centralized and decentralized model for offering clinically-actionable genomic insights at a global scale GAITHERSBURG, Md. & OAKLAND, Calif.–GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the successful completion of its acquisition of Fabric Genomics, a pioneer in […]

LINCOLN, Neb. — Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors. The latest system enhancements streamline laboratory documentation and improve operational efficiency for users. The updated platform also offers […]

PORTOLA VALLEY, CALIFORNIA / TeselaGen, a leading provider of AI-augmented design and automation software for biotechnology, announced the recent alpha release of its powerful agentic Copilot, seamlessly integrated with TeselaGen’s Platform for Biological R&D. This breakthrough solution harnesses advanced artificial intelligence to streamline experiment planning, accelerate data analysis, and enhance bioproduct development for researchers in […]

Financing led by Superhero Capital backed by NGL Ventures, Coinvest Capital and angel investors Building on strong international R&D customer base across biotech, pharma and academia Transforming multi-omics data into functional discoveries Addressing a potential USD 16 billion market VUGENE, a Lithuania-based multi-omics data analysis company, today announced the closing an investment round of €1 million, […]

PITTSBURGH and BRIDGEWATER, N.J. — PredxBio, a pioneer in AI-powered spatial biomarker discovery, today announced a strategic collaboration with Hamamatsu Photonics K.K., a global leader in imaging technologies. The partnership unites Hamamatsu’s advanced MoxiePlex™ multiplex immunofluorescence imaging system with PredxBio’s SpaceIQ™ spatial analytics platform to deliver an integrated workflow tailored to basic and translational research tailored to immuno-oncology. […]